Phase II study of induction docetaxel/cisplatin followed by concurrent pulsed docetaxel chemoradiation for stage III non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Pandya, Kishan J. [1 ]
Chen, Yuhchyau [1 ]
Hyrien, Ollieier [1 ]
Smudzin, Therese [1 ]
机构：
[1] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：229 / 229
页数：1
相关论文
共 50 条
  • [21] Phase I study to determine MTD of docetaxel and cisplatin with concurrent radiation therapy for stage III non-small cell lung cancer
    Li, You-quan
    Shi, An-hui
    Li, Fu-hai
    Yu, Rong
    Zhu, Guang-ying
    CHINESE JOURNAL OF CANCER RESEARCH, 2011, 23 (02) : 129 - 133
  • [22] Clinical Outcome of Palliative Concurrent Chemoradiotherapy with Cisplatin/Docetaxel for Stage III Non-small Cell Lung Cancer
    Katsui, Kuniaki
    Ogata, Takeshi
    Watanabe, Kenta
    Yoshio, Kotaro
    Kuroda, Masahiro
    Hiraki, Takao
    Kiura, Katsuyuki
    Maeda, Yoshinobu
    Toyooka, Shinichi
    Kanazawa, Susumu
    ACTA MEDICA OKAYAMA, 2021, 75 (03) : 269 - 277
  • [23] Phase II study of induction and adjuvant bevacizumab in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) receiving induction docetaxel and cisplatin
    Price, K.
    Kris, M. G.
    Rusch, V.
    Finley, D. J.
    Azzoli, C. G.
    Downey, R. J.
    Bains, M. S.
    Miller, V. A.
    Rizk, N.
    Rizvi, N. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Docetaxel (D) and cisplatin (C) induction chemotherapy followed by concurrent thoracic radiotherapy (TRT) and biweekly D and C for stage III non-small cell lung cancer (NSCLC): A Galician Lung Cancer Group study
    Casal, J.
    Varela, S.
    Anido, U.
    Lazaro, M.
    Firvida, J. L.
    Vazquez-Estevez, S.
    Villanueva, M.
    Amenedo, M.
    Caeiro, M.
    Gomez, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Docetaxel (D) and cisplatin (C) induction chemotherapy followed by bi-weekly D with concurrent thoracic radiotherapy for stage III non-small cell lung cancer (NSCLC): A Galician Lung Cancer Group study
    Huidobro, G.
    Vazquez, S.
    Lazaro, M.
    Mel, J. R.
    Casal, J.
    Castellanos, J.
    Vidal, Y.
    Firvida, J. L.
    Amenedo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] A phase II Study of administration of Docetaxel and Vinorelbine with Gemcitabine for inoperable Stage III or IV Non-Small Cell Lung Cancer (NSCLC)
    Reza, Md S.
    Hai, Mohammad A.
    Chowdhury, Qamruzzaman
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S708 - S709
  • [27] Phase II study of weekly docetaxel and cisplatin in patients with non-small cell lung cancer
    Kaira, K
    Takise, A
    Minato, K
    Iwasaki, Y
    Ishihara, S
    Takei, Y
    Tsuchiya, S
    Saito, R
    Sato, K
    Mori, M
    ANTI-CANCER DRUGS, 2005, 16 (04) : 455 - 460
  • [28] Concurrent chemo-radiotherapy with docetaxel-cisplatin followed by docetaxel consolidation therapy in inoperable stage IIIA/B non-small cell lung cancer (NSCLC): updated results of a Phase I study
    Huber, Rudoif M.
    Borgmeier, Astrid
    Flentje, Michael
    Willner, Jochen
    Schmidt, Michael
    Manegold, Christian
    Debus, Juergen
    ANNALS OF ONCOLOGY, 2004, 15 : 172 - 173
  • [29] Phase II study of induction chemotherapy followed by radiotherapy combined with daily cisplatin in stage III inoperable non-small cell lung cancer (NSCLC).
    Scolaro, T
    Ardizzoni, A
    Giudici, S
    Grossi, F
    Cosso, M
    Pennucci, MC
    Bacigalupo, A
    Rosso, R
    Vitale, V
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 313 - 313
  • [30] Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation (CCR) with biweekly gemcitabine in unresectable stage III non small cell lung cancer (NSCLC):: Final results of a phase II study
    Blanco, R
    Solé, J
    Nogué, M
    Montesinos, J
    Gallardo, E
    Vadell, C
    Mesía, C
    Algara, M
    Terrasa, J
    LUNG CANCER, 2005, 49 : S77 - S77
12345